200
Views
8
CrossRef citations to date
0
Altmetric
Myopia

Patterns of Fundus Autofluorescence in Eyes with Myopic Atrophy Maculopathy: A Consecutive Case Series Study

, , , , , , , & ORCID Icon show all
Pages 1056-1060 | Received 11 Aug 2020, Accepted 17 Nov 2020, Published online: 17 Dec 2020

References

  • Buch H, Vinding T, Nielsen NV. Prevalence and causes of visual impairment according to World Health Organization and United States criteria in an aged, urban Scandinavian population: the Copenhagen city eye study. Ophthalmology. 2001;108:2347–57. doi:10.1016/S0161-6420(01)00823-5.
  • Xu L, Wang Y, Li Y, Wang Y, Cui T, Li J, Jonas JB. Causes of blindness and visual impairment in urban and rural areas in Beijing: the Beijing eye study. Ophthalmology. 2006;113(1134):e1–11. doi:10.1016/j.ophtha.2006.01.035.
  • Iwase A, Araie M, Tomidokoro A, Yamamoto T, Shimizu H, Kitazawa Y, Tajimi Study G. Prevalence and causes of low vision and blindness in a Japanese adult population: the Tajimi study. Ophthalmology. 2006;113:1354–62. doi:10.1016/j.ophtha.2006.04.022.
  • Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo KS, Sankaridurg P, Wong TY, Naduvilath TJ, Resnikoff S. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016;123(5):1036–42. doi:10.1016/j.ophtha.2016.01.006.
  • Leveziel N, Marillet S, Dufour Q, Lichtwitz O, Bentaleb Y, Pelen F, Ingrand P, Bourne R. Prevalence of macular complications related to myopia - Results of a multicenter evaluation of myopic patients in eye clinics in France. Acta Ophthalmol. 2019;98:e245–e251. doi:10.1111/aos.14246.
  • Ohno-Matsui K, Kawasaki R, Jonas JB, Cheung CM, Saw S-M, Verhoeven VJ, Klaver CC, Moriyama M, Shinohara K, Kawasaki Y, et al.; Group ME-afPMS. International photographic classification and grading system for myopic maculopathy. Am J Ophthalmol. 2015;159:877-83;e7. doi:10.1016/j.ajo.2015.01.022.
  • Schmitz-Valckenberg S, Holz FG, Bird AC, Spaide RF. Fundus autofluorescence imaging: review and perspectives. Retina. 2008;28(3):385–409. doi:10.1097/IAE.0b013e318164a907.
  • Delori FC, Dorey CK, Staurenghi G, Arend O, Goger DG, Weiter JJ. In vivo fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin characteristics. Invest Ophthalmol Vis Sci. 1995;36:718–29.
  • Parodi MB, Iacono P, Sacconi R, Iuliano L, Bandello F. Fundus autofluorescence changes after ranibizumab treatment for subfoveal choroidal neovascularization secondary to pathologic myopia. Am J Ophthalmol. 2015;160(322–7):e2. doi:10.1016/j.ajo.2015.04.030.
  • Xu X, Fang Y, Uramoto K, Nagaoka N, Shinohara K, Yokoi T, Tanaka N, Clinical O-MK. Features of lacquer cracks in eyes with pathologic myopia. Retina. 2019;39:1265–77. doi:10.1097/IAE.0000000000002168.
  • Sayanagi K, Ikuno Y, Tano Y. Different fundus autofluorescence patterns of retinoschisis and macular hole retinal detachment in high myopia. Am J Ophthalmol. 2007;144(2):299–301. doi:10.1016/j.ajo.2007.03.049.
  • Miere A, Capuano V, Serra R, Jung C, Souied E, Querques G. Evaluation of patchy atrophy secondary to high myopia by semiautomated software for fundus autofluorescence analysis. Retina. 2018;38(7):1301–06. doi:10.1097/IAE.0000000000001733.
  • Fang Y, Yokoi T, Nagaoka N, Shinohara K, Onishi Y, Ishida T, Yoshida T, Xu X, Jonas JB, Ohno-Matsui K. Progression of myopic maculopathy during 18-year follow-up. Ophthalmology. 2018;125(6):863–77. doi:10.1016/j.ophtha.2017.12.005.
  • Hayashi K, Ohno-Matsui K, Shimada N, Moriyama M, Kojima A, Hayashi W, Yasuzumi K, Nagaoka N, Saka N, Yoshida T, et al. Long-term pattern of progression of myopic maculopathy: a natural history study. Ophthalmology. 2010;117(8):1595–611, 611 e1-4. doi:10.1016/j.ophtha.2009.11.003.
  • Asakuma T, Yasuda M, Ninomiya T, Noda Y, Arakawa S, Hashimoto S, Ohno-Matsui K, Kiyohara Y, Ishibashi T. Prevalence and risk factors for myopic retinopathy in a Japanese population: the Hisayama study. Ophthalmology. 2012;119(9):1760–65. doi:10.1016/j.ophtha.2012.02.034.
  • Chang L, Pan CW, Ohno-Matsui K, Lin X, Cheung GC, Gazzard G, Koh V, Hamzah H, Tai ES, Lim SC, et al. Myopia-related fundus changes in Singapore adults with high myopia. Am J Ophthalmol. 2013;155(991–9):e1. doi:10.1016/j.ajo.2013.01.016.
  • Shih YF, Ho TC, Hsiao CK, Lin LL. Visual outcomes for high myopic patients with or without myopic maculopathy: a 10 year follow up study. Br J Ophthalmol. 2006;90:546–50. doi:10.1136/bjo.2005.081992.
  • Wong CW, Phua V, Lee SY, Wong TY, Cheung CM. Is choroidal or scleral thickness related to myopic macular degeneration? Invest Ophthalmol Vis Sci. 2017;58(2):907–13. doi:10.1167/iovs.16-20742.
  • Nishida Y, Fujiwara T, Imamura Y, Lima LH, Kurosaka D, Spaide RF. Choroidal thickness and visual acuity in highly myopic eyes. Retina. 2012;32(7):1229–36. doi:10.1097/IAE.0b013e318242b990.
  • Domalpally A, Danis R, Agron E, Blodi B, Clemons T, Chew E. Age-related eye disease study 2 research G. Evaluation of geographic atrophy from color photographs and fundus autofluorescence images: age-related eye disease study 2 report number 11. Ophthalmology. 2016;123(11):2401–07. doi:10.1016/j.ophtha.2016.06.025.
  • Holmen IC, Aul B, Pak JW, Trane RM, Blodi B, Klein M, Clemons T, Chew E, Domalpally A. Age-related eye disease study 2 research G. Precursors and development of geographic atrophy with autofluorescence imaging: age-related eye disease study 2 report number 18. Ophthalmol Retina. 2019;3(9):724–33. doi:10.1016/j.oret.2019.04.011.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.